EANS-News: Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products Vienna, Austria, October 30, 2009 (euro adhoc) - Intercell AG (VSE: ICLL) today announced that the Health Canada granted product approval for IXIARO®, the company's ...